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Luciferise(Luc)和 Green fluorescent protein (GFP)基因的质粒载体，并用工具细胞
株（人胚肾细胞 293FT）进行慢病毒包装，收集慢病毒后感染神经胶质瘤细胞
（U87、U251、C6），使神经胶质瘤细胞标记上 GFP 和 Luc 双荧光，再经过流
式细胞仪的 GFP 荧光筛选后获得稳定表达 GFP-Luc 荧光的三种胶质瘤细胞系，
并用活体发光成像系统检测 Luc 的发光强度,采用一元线性回归分析法分析发光
强度与细胞数量的相关性。以荧光胶质瘤细胞实验组，原始胶质瘤细胞为对照组，








1. 成功包装含 GFP 和 Luc 基因的慢病毒，并用慢病毒感染 C6、U87、U251


















3. 活体发光成像系统检测 Luc 的发光强度结果显示,Luc 发光强度与细胞数





新生血管，成瘤率 100％，裸鼠中位生存期 25 天；U251 肿瘤与正常脑组织界限
不清，可见明显细胞坏死团，裸鼠模型成瘤率（90％），中位生存期 29 天； C6




























Background：Glioma is the most common primary intracranial tumor in the central 
nervous system, which accounts for 81% of malignant brain tumors，Although the 
incidence is low, its mortality is extremely high. With the development of glioma 
research ，a variety of new ideas of treatment have been put into preclinical and clinica l 
practice applications，but the effect is minimal，successful animal experiments but poor 
clinical evaluation experience shows that the animal model does not reflect the true 
physiological characteristics of the patient's tumor, It is urgent to establish reliable and 
stable glioma orthotopic transplantation model for glioma research. 
Objective : To construct glioma fluorescence stable cell lines, and to establish a 
novel model of orthotopic xenograft tumor in nude mice which can monitor tumor 
growth in real time, and compare three different glioma orthotopic models. 
Methods : Three differents glioma cell lines (U87, U251, C6 ) were selected as the 
research object. The plasmid vectors containing Luciferise gene and Green fluorescent 
using lentivirus kit and human embryonic kidney cell (293FT) and extracted to 
influence glioma cells. Most glioma cells were labeled with GFP and Luc fluorescence after 
influencing by lentivirus. After screening by flow cytometry, three glioma cell lines 
stably expressing GFP-Luc fluorescence were obtained. Then the relationship between 
luminous intensity and cell number was detected by living luminescence imaging 
system, and the results were analyzed by one-dimensional linear regression. Cells with 
GFP-Luc fluorescence were as experimental groups and the cells without fluorescence 
were as control groups. In order to evaluate the biological characteristics of GFP-Luc 
fluorescence cells not influenced by the fluoyescent gene, the proliferation, cycle, 
metastasis and invasion ability of fluorescent cells and control cells were evaluated by 
CCK-8 test, cell cycle test, transwell tumor invasion and migration experiment. Then 















Caudate nucleus of athymic nude mices by stereotaxic device respectively to establish 
thotopic tumor model. Intracerebral tumor growth was monitored in real time by small 
animal bioluminescence imaging (BLI) system. Hematoxylin-eosin staining(HE) was 
used to evaluate the pathological features and tumorigenicity of each cell line in the 
brain of nude mice. 
Result : 
1. The vector with GFP and Luciferise gene was packaged successfully 
C6,U87 and 
U251. GFP was expressed in about 90% glioma cells under fluorescence microscopy; 
2. Flow cytometry was used to screen the cells with fluorescence and the cells 
remain without fluorescent signal attenuation after continuous 6-8 generation. Cells 
stable expressing fluorescence were obtained. The cells with fluorescence were named 
as U87-GFP-Luc, U251-GFP-Luc, C6 -GFP-Luc; 
3. The results of in vivo bioluminescence imaging system showed that the 
intensity of Luc showed a good correlation with the number of fluorescent cells. The 
R2 of U87-GFP-Luc, U251-GFP-Luc and C6-GFP-Luc were 0.9957, 0.9920 and 
0.9782, respectively; 
4. The results of cell function showed that, there were no statistically significant 
differences between the control group and the experimental group in the proliferat ion, 
cell cycle distribution, migration and invasion abilities (P> 0.05); 
5. HE staining results showed that, U87- glioma nude mice model: boundaries of 
tumor tissue was clear, HE sections showed obvious neovascularization, tumor 
formation rate was 100%. The median survival period was 25 days in nude mice; U251- 
glioma nude mice model: the boundary between tumor and normal brain tissue was 
unclear, HE sections showed visible cell necrosis group, The tumor formation rate was 
90%, median survival time was 29 days；C6 - glioma nude mice model could be seen 
obvious nuclear atypia, tumor formation rate was 70%, the median survival period was 
31 days. 
Conclusion: 
















2. Compared to traditional glioblastoma cells, GFP-Luc-transfected human 
glioblastoma cells were more beneficial to the study of glioblastoma;  
3. U87- glioma nude mice model:tumor formation rate was 100%, the groth of 
tumor was stable in intracranial, without extracranial metastasis and had moderate 
experimental cycle, sections showed obvious neovascularization and the model is 
suitable for glioma vascular formation and anti angiogenic therapy research; 
4. U251- nude mice model had high tumor formation rate (90%). The survival time 
of this model was not very stable, however, the tumor growth and pathologica l 
characteristics were similar to that of human glioma; 
5. C6- nude mice tumor formation rate lower slightly (75%), a large number of 
model appeared extracranial tumor growth which suggesting that this cell line may not 
be suitable for planting in the nude mice. 
















英文缩写 英文全名 中文名称 
GFP green fluorescent protein 绿色荧光蛋白 
PEI Polyethylenimine  聚乙烯亚胺 
RFP Red fluorescent protein 红色荧光蛋白 
CCK-8 Cell Counting Kit-8 细胞计数试剂盒 
Luc Luciferase 荧光素酶 
HE Hematoxylin-eosin  苏木精-伊红染色 
BLI Bioluminescence imaging 生物发光成像 
CT Compute Tomography X 射线计算机断层摄影 
PET Positron Emission Tomography 正电子发射计算机断层显像 
MRI Magnetic resonance imaging 磁共振成像 
FBS Fetal Bovine Serum 胎牛血清 
OD Optical density 光密度值 
PBS Phosphate buffered saline 磷酸盐缓冲液 
BBB blood brain barrier 血脑屏障 
CCD charge-coupled device 电荷耦合器件 
Luc Luciferase 荧光素酶 
SOB  Super Optimal Broth 超级营养培养基 
DNA Deoxyribonucleic Acid 脱氧核糖核酸 
SB Standard buffer 标准缓冲液 















TE Tris-EDTA TE 缓冲液 
RNase Ribonuclease 核糖核酸酶 
LB Lysogeny broth 溶原性培养基 
PH hydrogen ion concentration 氢离子浓度 
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100000，每年大约有 10000 例新发胶质母细胞瘤和 4000 例 III 级胶质瘤的病例被
确诊[3]。胶质母细胞瘤在男性的发病率较高，诊断的平均年分别为：胶质母细胞






质母细胞瘤患者的中位生存期约为 14 个月至 16 个月。III 级胶质瘤中的间变性
星形细胞瘤患者的中位生存期为 3-5 年，间变性少突胶质细胞瘤患者的中位生存
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